Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
218.9 USD | -1.13% | +1.91% | -15.40% |
02:28pm | Redburn Atlantic Adjusts Price Target on Biogen to $235 From $275, Keeps Neutral Rating | MT |
May. 07 | FDA Sets June 10 Advisory Panel Meeting on Eli Lilly Alzheimer's Drug | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.40% | 31.87B | |
-2.35% | 89.33B | |
+3.29% | 41.19B | |
+53.68% | 24.52B | |
-14.35% | 15.68B | |
-6.52% | 12.34B | |
-39.65% | 12.23B | |
+6.22% | 8.83B | |
-6.43% | 8.28B | |
-0.57% | 7.52B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Guggenheim Adjusts Price Target on Biogen to $255 From $275